nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosinopril—Lisinopril—systemic scleroderma	0.337	1	CrCtD
Fosinopril—ACE—systemic scleroderma	0.173	1	CbGaD
Fosinopril—Enalapril—Captopril—systemic scleroderma	0.0802	0.371	CrCrCtD
Fosinopril—ACE—Lisinopril—systemic scleroderma	0.0798	0.408	CbGbCtD
Fosinopril—ACE—Captopril—systemic scleroderma	0.0597	0.306	CbGbCtD
Fosinopril—SLC15A1—Lisinopril—systemic scleroderma	0.032	0.164	CbGbCtD
Fosinopril—Spirapril—Lisinopril—systemic scleroderma	0.0282	0.131	CrCrCtD
Fosinopril—Cilazapril—Lisinopril—systemic scleroderma	0.0282	0.131	CrCrCtD
Fosinopril—Enalapril—Lisinopril—systemic scleroderma	0.0265	0.122	CrCrCtD
Fosinopril—Trandolapril—Lisinopril—systemic scleroderma	0.0265	0.122	CrCrCtD
Fosinopril—Ramipril—Lisinopril—systemic scleroderma	0.0265	0.122	CrCrCtD
Fosinopril—SLC15A1—Captopril—systemic scleroderma	0.024	0.123	CbGbCtD
Fosinopril—ACE—forelimb zeugopod—systemic scleroderma	0.00375	0.24	CbGeAlD
Fosinopril—ACE—pulmonary artery—systemic scleroderma	0.00281	0.18	CbGeAlD
Fosinopril—ACE—skeletal joint—systemic scleroderma	0.00249	0.159	CbGeAlD
Fosinopril—ACE—umbilical vein—systemic scleroderma	0.00186	0.119	CbGeAlD
Fosinopril—ACE—artery—systemic scleroderma	0.00104	0.0666	CbGeAlD
Fosinopril—ACE—endothelium—systemic scleroderma	0.000879	0.0563	CbGeAlD
Fosinopril—ACE—blood vessel—systemic scleroderma	0.000811	0.0519	CbGeAlD
Fosinopril—SLC15A1—digestive system—systemic scleroderma	0.000419	0.0268	CbGeAlD
Fosinopril—ACE—connective tissue—systemic scleroderma	0.000416	0.0266	CbGeAlD
Fosinopril—ACE—smooth muscle tissue—systemic scleroderma	0.00038	0.0243	CbGeAlD
Fosinopril—ACE—digestive system—systemic scleroderma	0.0003	0.0192	CbGeAlD
Fosinopril—Spirapril—ACE—systemic scleroderma	0.000284	0.194	CrCbGaD
Fosinopril—Lisinopril—ACE—systemic scleroderma	0.000254	0.173	CrCbGaD
Fosinopril—Cilazapril—ACE—systemic scleroderma	0.000254	0.173	CrCbGaD
Fosinopril—ACE—lung—systemic scleroderma	0.000251	0.0161	CbGeAlD
Fosinopril—Trandolapril—ACE—systemic scleroderma	0.000246	0.167	CrCbGaD
Fosinopril—Ramipril—ACE—systemic scleroderma	0.000246	0.167	CrCbGaD
Fosinopril—SLC15A2—lung—systemic scleroderma	0.000219	0.014	CbGeAlD
Fosinopril—Enalapril—ACE—systemic scleroderma	0.000186	0.127	CrCbGaD
Fosinopril—Dyspepsia—Mycophenolic acid—systemic scleroderma	2.55e-05	0.000412	CcSEcCtD
Fosinopril—Neutropenia—Prednisone—systemic scleroderma	2.55e-05	0.000412	CcSEcCtD
Fosinopril—Tachycardia—Lisinopril—systemic scleroderma	2.55e-05	0.000411	CcSEcCtD
Fosinopril—Body temperature increased—Azathioprine—systemic scleroderma	2.54e-05	0.000411	CcSEcCtD
Fosinopril—Abdominal pain—Azathioprine—systemic scleroderma	2.54e-05	0.000411	CcSEcCtD
Fosinopril—Malaise—Mycophenolate mofetil—systemic scleroderma	2.53e-05	0.000408	CcSEcCtD
Fosinopril—Hyperhidrosis—Lisinopril—systemic scleroderma	2.52e-05	0.000407	CcSEcCtD
Fosinopril—Diarrhoea—Captopril—systemic scleroderma	2.52e-05	0.000407	CcSEcCtD
Fosinopril—Decreased appetite—Mycophenolic acid—systemic scleroderma	2.52e-05	0.000407	CcSEcCtD
Fosinopril—Vertigo—Mycophenolate mofetil—systemic scleroderma	2.52e-05	0.000406	CcSEcCtD
Fosinopril—Syncope—Mycophenolate mofetil—systemic scleroderma	2.51e-05	0.000406	CcSEcCtD
Fosinopril—Erectile dysfunction—Prednisone—systemic scleroderma	2.51e-05	0.000405	CcSEcCtD
Fosinopril—Leukopenia—Mycophenolate mofetil—systemic scleroderma	2.51e-05	0.000405	CcSEcCtD
Fosinopril—Feeling abnormal—Leflunomide—systemic scleroderma	2.5e-05	0.000404	CcSEcCtD
Fosinopril—Fatigue—Mycophenolic acid—systemic scleroderma	2.5e-05	0.000403	CcSEcCtD
Fosinopril—Mood swings—Methotrexate—systemic scleroderma	2.5e-05	0.000403	CcSEcCtD
Fosinopril—Nausea—Mometasone—systemic scleroderma	2.49e-05	0.000402	CcSEcCtD
Fosinopril—Anorexia—Lisinopril—systemic scleroderma	2.49e-05	0.000402	CcSEcCtD
Fosinopril—Gastrointestinal pain—Leflunomide—systemic scleroderma	2.48e-05	0.000401	CcSEcCtD
Fosinopril—Weight increased—Prednisone—systemic scleroderma	2.48e-05	0.000401	CcSEcCtD
Fosinopril—Pain—Mycophenolic acid—systemic scleroderma	2.48e-05	0.0004	CcSEcCtD
Fosinopril—Constipation—Mycophenolic acid—systemic scleroderma	2.48e-05	0.0004	CcSEcCtD
Fosinopril—Palpitations—Mycophenolate mofetil—systemic scleroderma	2.47e-05	0.0004	CcSEcCtD
Fosinopril—Weight decreased—Prednisone—systemic scleroderma	2.46e-05	0.000398	CcSEcCtD
Fosinopril—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	2.46e-05	0.000398	CcSEcCtD
Fosinopril—Cough—Mycophenolate mofetil—systemic scleroderma	2.44e-05	0.000395	CcSEcCtD
Fosinopril—Hypotension—Lisinopril—systemic scleroderma	2.44e-05	0.000394	CcSEcCtD
Fosinopril—Dizziness—Captopril—systemic scleroderma	2.44e-05	0.000393	CcSEcCtD
Fosinopril—Hypertension—Mycophenolate mofetil—systemic scleroderma	2.42e-05	0.000391	CcSEcCtD
Fosinopril—Urticaria—Leflunomide—systemic scleroderma	2.41e-05	0.00039	CcSEcCtD
Fosinopril—Abdominal pain—Leflunomide—systemic scleroderma	2.4e-05	0.000388	CcSEcCtD
Fosinopril—Body temperature increased—Leflunomide—systemic scleroderma	2.4e-05	0.000388	CcSEcCtD
Fosinopril—Acute coronary syndrome—Prednisone—systemic scleroderma	2.39e-05	0.000387	CcSEcCtD
Fosinopril—Feeling abnormal—Mycophenolic acid—systemic scleroderma	2.39e-05	0.000386	CcSEcCtD
Fosinopril—Chest pain—Mycophenolate mofetil—systemic scleroderma	2.38e-05	0.000385	CcSEcCtD
Fosinopril—Arthralgia—Mycophenolate mofetil—systemic scleroderma	2.38e-05	0.000385	CcSEcCtD
Fosinopril—Myalgia—Mycophenolate mofetil—systemic scleroderma	2.38e-05	0.000385	CcSEcCtD
Fosinopril—Myocardial infarction—Prednisone—systemic scleroderma	2.38e-05	0.000385	CcSEcCtD
Fosinopril—Neuropathy peripheral—Prednisone—systemic scleroderma	2.38e-05	0.000385	CcSEcCtD
Fosinopril—Breast disorder—Methotrexate—systemic scleroderma	2.38e-05	0.000385	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	2.38e-05	0.000384	CcSEcCtD
Fosinopril—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	2.37e-05	0.000383	CcSEcCtD
Fosinopril—Hypersensitivity—Azathioprine—systemic scleroderma	2.37e-05	0.000383	CcSEcCtD
Fosinopril—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	2.37e-05	0.000383	CcSEcCtD
Fosinopril—Insomnia—Lisinopril—systemic scleroderma	2.36e-05	0.000381	CcSEcCtD
Fosinopril—Discomfort—Mycophenolate mofetil—systemic scleroderma	2.36e-05	0.000381	CcSEcCtD
Fosinopril—Paraesthesia—Lisinopril—systemic scleroderma	2.34e-05	0.000378	CcSEcCtD
Fosinopril—Vomiting—Captopril—systemic scleroderma	2.34e-05	0.000378	CcSEcCtD
Fosinopril—Dry mouth—Mycophenolate mofetil—systemic scleroderma	2.33e-05	0.000377	CcSEcCtD
Fosinopril—Dyspnoea—Lisinopril—systemic scleroderma	2.33e-05	0.000376	CcSEcCtD
Fosinopril—Rash—Captopril—systemic scleroderma	2.32e-05	0.000375	CcSEcCtD
Fosinopril—Dermatitis—Captopril—systemic scleroderma	2.32e-05	0.000375	CcSEcCtD
Fosinopril—Somnolence—Lisinopril—systemic scleroderma	2.32e-05	0.000375	CcSEcCtD
Fosinopril—Headache—Captopril—systemic scleroderma	2.31e-05	0.000373	CcSEcCtD
Fosinopril—Confusional state—Mycophenolate mofetil—systemic scleroderma	2.3e-05	0.000372	CcSEcCtD
Fosinopril—Dyspepsia—Lisinopril—systemic scleroderma	2.3e-05	0.000371	CcSEcCtD
Fosinopril—Body temperature increased—Mycophenolic acid—systemic scleroderma	2.29e-05	0.00037	CcSEcCtD
Fosinopril—Abdominal pain—Mycophenolic acid—systemic scleroderma	2.29e-05	0.00037	CcSEcCtD
Fosinopril—Oedema—Mycophenolate mofetil—systemic scleroderma	2.29e-05	0.000369	CcSEcCtD
Fosinopril—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	2.29e-05	0.000369	CcSEcCtD
Fosinopril—Asthma—Methotrexate—systemic scleroderma	2.28e-05	0.000368	CcSEcCtD
Fosinopril—Infection—Mycophenolate mofetil—systemic scleroderma	2.27e-05	0.000367	CcSEcCtD
Fosinopril—Decreased appetite—Lisinopril—systemic scleroderma	2.27e-05	0.000366	CcSEcCtD
Fosinopril—Eosinophilia—Methotrexate—systemic scleroderma	2.25e-05	0.000364	CcSEcCtD
Fosinopril—Fatigue—Lisinopril—systemic scleroderma	2.25e-05	0.000363	CcSEcCtD
Fosinopril—Shock—Mycophenolate mofetil—systemic scleroderma	2.25e-05	0.000363	CcSEcCtD
Fosinopril—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	2.24e-05	0.000361	CcSEcCtD
Fosinopril—Hypersensitivity—Leflunomide—systemic scleroderma	2.24e-05	0.000361	CcSEcCtD
Fosinopril—Pancreatitis—Methotrexate—systemic scleroderma	2.23e-05	0.000361	CcSEcCtD
Fosinopril—Constipation—Lisinopril—systemic scleroderma	2.23e-05	0.00036	CcSEcCtD
Fosinopril—Pain—Lisinopril—systemic scleroderma	2.23e-05	0.00036	CcSEcCtD
Fosinopril—Tachycardia—Mycophenolate mofetil—systemic scleroderma	2.23e-05	0.00036	CcSEcCtD
Fosinopril—Bradycardia—Prednisone—systemic scleroderma	2.22e-05	0.000359	CcSEcCtD
Fosinopril—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	2.21e-05	0.000357	CcSEcCtD
Fosinopril—Diarrhoea—Azathioprine—systemic scleroderma	2.2e-05	0.000355	CcSEcCtD
Fosinopril—Haemoglobin—Prednisone—systemic scleroderma	2.19e-05	0.000354	CcSEcCtD
Fosinopril—Nausea—Captopril—systemic scleroderma	2.19e-05	0.000353	CcSEcCtD
Fosinopril—Haemorrhage—Prednisone—systemic scleroderma	2.18e-05	0.000352	CcSEcCtD
Fosinopril—Anorexia—Mycophenolate mofetil—systemic scleroderma	2.18e-05	0.000352	CcSEcCtD
Fosinopril—Asthenia—Leflunomide—systemic scleroderma	2.18e-05	0.000352	CcSEcCtD
Fosinopril—Hallucination—Prednisone—systemic scleroderma	2.17e-05	0.00035	CcSEcCtD
Fosinopril—Pancytopenia—Methotrexate—systemic scleroderma	2.16e-05	0.000349	CcSEcCtD
Fosinopril—Feeling abnormal—Lisinopril—systemic scleroderma	2.15e-05	0.000347	CcSEcCtD
Fosinopril—Pruritus—Leflunomide—systemic scleroderma	2.15e-05	0.000347	CcSEcCtD
Fosinopril—Hypotension—Mycophenolate mofetil—systemic scleroderma	2.14e-05	0.000345	CcSEcCtD
Fosinopril—Gastrointestinal pain—Lisinopril—systemic scleroderma	2.13e-05	0.000345	CcSEcCtD
Fosinopril—Neutropenia—Methotrexate—systemic scleroderma	2.13e-05	0.000344	CcSEcCtD
Fosinopril—Dizziness—Azathioprine—systemic scleroderma	2.13e-05	0.000343	CcSEcCtD
Fosinopril—Upper respiratory tract infection—Methotrexate—systemic scleroderma	2.12e-05	0.000342	CcSEcCtD
Fosinopril—Erectile dysfunction—Methotrexate—systemic scleroderma	2.1e-05	0.000339	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	2.08e-05	0.000336	CcSEcCtD
Fosinopril—Photosensitivity reaction—Methotrexate—systemic scleroderma	2.08e-05	0.000336	CcSEcCtD
Fosinopril—Asthenia—Mycophenolic acid—systemic scleroderma	2.08e-05	0.000336	CcSEcCtD
Fosinopril—Diarrhoea—Leflunomide—systemic scleroderma	2.08e-05	0.000336	CcSEcCtD
Fosinopril—Urticaria—Lisinopril—systemic scleroderma	2.07e-05	0.000335	CcSEcCtD
Fosinopril—Insomnia—Mycophenolate mofetil—systemic scleroderma	2.07e-05	0.000334	CcSEcCtD
Fosinopril—Abdominal pain—Lisinopril—systemic scleroderma	2.06e-05	0.000333	CcSEcCtD
Fosinopril—Body temperature increased—Lisinopril—systemic scleroderma	2.06e-05	0.000333	CcSEcCtD
Fosinopril—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	2.05e-05	0.000332	CcSEcCtD
Fosinopril—Pruritus—Mycophenolic acid—systemic scleroderma	2.05e-05	0.000331	CcSEcCtD
Fosinopril—Vomiting—Azathioprine—systemic scleroderma	2.04e-05	0.00033	CcSEcCtD
Fosinopril—Pneumonia—Methotrexate—systemic scleroderma	2.04e-05	0.00033	CcSEcCtD
Fosinopril—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	2.04e-05	0.000329	CcSEcCtD
Fosinopril—Somnolence—Mycophenolate mofetil—systemic scleroderma	2.03e-05	0.000328	CcSEcCtD
Fosinopril—Drowsiness—Methotrexate—systemic scleroderma	2.03e-05	0.000328	CcSEcCtD
Fosinopril—Rash—Azathioprine—systemic scleroderma	2.03e-05	0.000327	CcSEcCtD
Fosinopril—Dermatitis—Azathioprine—systemic scleroderma	2.02e-05	0.000327	CcSEcCtD
Fosinopril—Flushing—Prednisone—systemic scleroderma	2.02e-05	0.000327	CcSEcCtD
Fosinopril—Headache—Azathioprine—systemic scleroderma	2.01e-05	0.000325	CcSEcCtD
Fosinopril—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	2.01e-05	0.000325	CcSEcCtD
Fosinopril—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	2.01e-05	0.000325	CcSEcCtD
Fosinopril—Dizziness—Leflunomide—systemic scleroderma	2.01e-05	0.000324	CcSEcCtD
Fosinopril—Renal failure—Methotrexate—systemic scleroderma	2e-05	0.000322	CcSEcCtD
Fosinopril—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	1.99e-05	0.000321	CcSEcCtD
Fosinopril—Diarrhoea—Mycophenolic acid—systemic scleroderma	1.98e-05	0.00032	CcSEcCtD
Fosinopril—Constipation—Mycophenolate mofetil—systemic scleroderma	1.95e-05	0.000316	CcSEcCtD
Fosinopril—Pain—Mycophenolate mofetil—systemic scleroderma	1.95e-05	0.000316	CcSEcCtD
Fosinopril—Arrhythmia—Prednisone—systemic scleroderma	1.95e-05	0.000315	CcSEcCtD
Fosinopril—Vomiting—Leflunomide—systemic scleroderma	1.93e-05	0.000312	CcSEcCtD
Fosinopril—Hypersensitivity—Lisinopril—systemic scleroderma	1.92e-05	0.00031	CcSEcCtD
Fosinopril—Dizziness—Mycophenolic acid—systemic scleroderma	1.92e-05	0.000309	CcSEcCtD
Fosinopril—Epistaxis—Methotrexate—systemic scleroderma	1.91e-05	0.000309	CcSEcCtD
Fosinopril—Rash—Leflunomide—systemic scleroderma	1.91e-05	0.000309	CcSEcCtD
Fosinopril—Dermatitis—Leflunomide—systemic scleroderma	1.91e-05	0.000309	CcSEcCtD
Fosinopril—Nausea—Azathioprine—systemic scleroderma	1.91e-05	0.000308	CcSEcCtD
Fosinopril—Headache—Leflunomide—systemic scleroderma	1.9e-05	0.000307	CcSEcCtD
Fosinopril—Agranulocytosis—Methotrexate—systemic scleroderma	1.89e-05	0.000306	CcSEcCtD
Fosinopril—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	1.88e-05	0.000304	CcSEcCtD
Fosinopril—Asthenia—Lisinopril—systemic scleroderma	1.87e-05	0.000302	CcSEcCtD
Fosinopril—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	1.87e-05	0.000302	CcSEcCtD
Fosinopril—Pruritus—Lisinopril—systemic scleroderma	1.85e-05	0.000298	CcSEcCtD
Fosinopril—Vomiting—Mycophenolic acid—systemic scleroderma	1.84e-05	0.000297	CcSEcCtD
Fosinopril—Haemoglobin—Methotrexate—systemic scleroderma	1.83e-05	0.000296	CcSEcCtD
Fosinopril—Rash—Mycophenolic acid—systemic scleroderma	1.83e-05	0.000295	CcSEcCtD
Fosinopril—Dermatitis—Mycophenolic acid—systemic scleroderma	1.82e-05	0.000295	CcSEcCtD
Fosinopril—Haemorrhage—Methotrexate—systemic scleroderma	1.82e-05	0.000294	CcSEcCtD
Fosinopril—Hepatitis—Methotrexate—systemic scleroderma	1.82e-05	0.000294	CcSEcCtD
Fosinopril—Urticaria—Mycophenolate mofetil—systemic scleroderma	1.82e-05	0.000293	CcSEcCtD
Fosinopril—Headache—Mycophenolic acid—systemic scleroderma	1.81e-05	0.000293	CcSEcCtD
Fosinopril—Pharyngitis—Methotrexate—systemic scleroderma	1.81e-05	0.000292	CcSEcCtD
Fosinopril—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	1.81e-05	0.000292	CcSEcCtD
Fosinopril—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	1.81e-05	0.000292	CcSEcCtD
Fosinopril—Nausea—Leflunomide—systemic scleroderma	1.8e-05	0.000291	CcSEcCtD
Fosinopril—Vision blurred—Prednisone—systemic scleroderma	1.79e-05	0.000289	CcSEcCtD
Fosinopril—Diarrhoea—Lisinopril—systemic scleroderma	1.78e-05	0.000288	CcSEcCtD
Fosinopril—Ill-defined disorder—Prednisone—systemic scleroderma	1.76e-05	0.000285	CcSEcCtD
Fosinopril—Visual impairment—Methotrexate—systemic scleroderma	1.76e-05	0.000284	CcSEcCtD
Fosinopril—Anaemia—Prednisone—systemic scleroderma	1.75e-05	0.000283	CcSEcCtD
Fosinopril—Agitation—Prednisone—systemic scleroderma	1.74e-05	0.000282	CcSEcCtD
Fosinopril—Angioedema—Prednisone—systemic scleroderma	1.73e-05	0.00028	CcSEcCtD
Fosinopril—Dizziness—Lisinopril—systemic scleroderma	1.72e-05	0.000279	CcSEcCtD
Fosinopril—Erythema multiforme—Methotrexate—systemic scleroderma	1.72e-05	0.000278	CcSEcCtD
Fosinopril—Nausea—Mycophenolic acid—systemic scleroderma	1.72e-05	0.000278	CcSEcCtD
Fosinopril—Malaise—Prednisone—systemic scleroderma	1.71e-05	0.000277	CcSEcCtD
Fosinopril—Vertigo—Prednisone—systemic scleroderma	1.71e-05	0.000276	CcSEcCtD
Fosinopril—Syncope—Prednisone—systemic scleroderma	1.7e-05	0.000275	CcSEcCtD
Fosinopril—Tinnitus—Methotrexate—systemic scleroderma	1.7e-05	0.000274	CcSEcCtD
Fosinopril—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	1.68e-05	0.000272	CcSEcCtD
Fosinopril—Loss of consciousness—Prednisone—systemic scleroderma	1.67e-05	0.00027	CcSEcCtD
Fosinopril—Vomiting—Lisinopril—systemic scleroderma	1.66e-05	0.000268	CcSEcCtD
Fosinopril—Rash—Lisinopril—systemic scleroderma	1.64e-05	0.000266	CcSEcCtD
Fosinopril—Dermatitis—Lisinopril—systemic scleroderma	1.64e-05	0.000265	CcSEcCtD
Fosinopril—Asthenia—Mycophenolate mofetil—systemic scleroderma	1.64e-05	0.000265	CcSEcCtD
Fosinopril—Hypertension—Prednisone—systemic scleroderma	1.64e-05	0.000265	CcSEcCtD
Fosinopril—Chills—Methotrexate—systemic scleroderma	1.64e-05	0.000264	CcSEcCtD
Fosinopril—Headache—Lisinopril—systemic scleroderma	1.63e-05	0.000264	CcSEcCtD
Fosinopril—Pruritus—Mycophenolate mofetil—systemic scleroderma	1.62e-05	0.000261	CcSEcCtD
Fosinopril—Myalgia—Prednisone—systemic scleroderma	1.62e-05	0.000261	CcSEcCtD
Fosinopril—Arthralgia—Prednisone—systemic scleroderma	1.62e-05	0.000261	CcSEcCtD
Fosinopril—Discomfort—Prednisone—systemic scleroderma	1.6e-05	0.000258	CcSEcCtD
Fosinopril—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	1.56e-05	0.000253	CcSEcCtD
Fosinopril—Dysgeusia—Methotrexate—systemic scleroderma	1.55e-05	0.000251	CcSEcCtD
Fosinopril—Nausea—Lisinopril—systemic scleroderma	1.55e-05	0.00025	CcSEcCtD
Fosinopril—Oedema—Prednisone—systemic scleroderma	1.55e-05	0.00025	CcSEcCtD
Fosinopril—Anaphylactic shock—Prednisone—systemic scleroderma	1.55e-05	0.00025	CcSEcCtD
Fosinopril—Infection—Prednisone—systemic scleroderma	1.54e-05	0.000249	CcSEcCtD
Fosinopril—Shock—Prednisone—systemic scleroderma	1.52e-05	0.000246	CcSEcCtD
Fosinopril—Tachycardia—Prednisone—systemic scleroderma	1.51e-05	0.000244	CcSEcCtD
Fosinopril—Dizziness—Mycophenolate mofetil—systemic scleroderma	1.51e-05	0.000244	CcSEcCtD
Fosinopril—Hyperhidrosis—Prednisone—systemic scleroderma	1.5e-05	0.000242	CcSEcCtD
Fosinopril—Vision blurred—Methotrexate—systemic scleroderma	1.5e-05	0.000242	CcSEcCtD
Fosinopril—Anorexia—Prednisone—systemic scleroderma	1.48e-05	0.000239	CcSEcCtD
Fosinopril—Ill-defined disorder—Methotrexate—systemic scleroderma	1.47e-05	0.000238	CcSEcCtD
Fosinopril—Anaemia—Methotrexate—systemic scleroderma	1.47e-05	0.000237	CcSEcCtD
Fosinopril—Vomiting—Mycophenolate mofetil—systemic scleroderma	1.45e-05	0.000235	CcSEcCtD
Fosinopril—Rash—Mycophenolate mofetil—systemic scleroderma	1.44e-05	0.000233	CcSEcCtD
Fosinopril—Dermatitis—Mycophenolate mofetil—systemic scleroderma	1.44e-05	0.000233	CcSEcCtD
Fosinopril—Headache—Mycophenolate mofetil—systemic scleroderma	1.43e-05	0.000231	CcSEcCtD
Fosinopril—Malaise—Methotrexate—systemic scleroderma	1.43e-05	0.000231	CcSEcCtD
Fosinopril—Vertigo—Methotrexate—systemic scleroderma	1.43e-05	0.00023	CcSEcCtD
Fosinopril—Leukopenia—Methotrexate—systemic scleroderma	1.42e-05	0.000229	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Prednisone—systemic scleroderma	1.41e-05	0.000228	CcSEcCtD
Fosinopril—Insomnia—Prednisone—systemic scleroderma	1.4e-05	0.000226	CcSEcCtD
Fosinopril—Paraesthesia—Prednisone—systemic scleroderma	1.39e-05	0.000225	CcSEcCtD
Fosinopril—Cough—Methotrexate—systemic scleroderma	1.38e-05	0.000224	CcSEcCtD
Fosinopril—Dyspepsia—Prednisone—systemic scleroderma	1.36e-05	0.00022	CcSEcCtD
Fosinopril—Nausea—Mycophenolate mofetil—systemic scleroderma	1.36e-05	0.000219	CcSEcCtD
Fosinopril—Chest pain—Methotrexate—systemic scleroderma	1.35e-05	0.000218	CcSEcCtD
Fosinopril—Arthralgia—Methotrexate—systemic scleroderma	1.35e-05	0.000218	CcSEcCtD
Fosinopril—Myalgia—Methotrexate—systemic scleroderma	1.35e-05	0.000218	CcSEcCtD
Fosinopril—Decreased appetite—Prednisone—systemic scleroderma	1.35e-05	0.000218	CcSEcCtD
Fosinopril—Fatigue—Prednisone—systemic scleroderma	1.34e-05	0.000216	CcSEcCtD
Fosinopril—Discomfort—Methotrexate—systemic scleroderma	1.33e-05	0.000216	CcSEcCtD
Fosinopril—Constipation—Prednisone—systemic scleroderma	1.32e-05	0.000214	CcSEcCtD
Fosinopril—Confusional state—Methotrexate—systemic scleroderma	1.31e-05	0.000211	CcSEcCtD
Fosinopril—Anaphylactic shock—Methotrexate—systemic scleroderma	1.29e-05	0.000209	CcSEcCtD
Fosinopril—Infection—Methotrexate—systemic scleroderma	1.29e-05	0.000208	CcSEcCtD
Fosinopril—Feeling abnormal—Prednisone—systemic scleroderma	1.28e-05	0.000206	CcSEcCtD
Fosinopril—Thrombocytopenia—Methotrexate—systemic scleroderma	1.27e-05	0.000205	CcSEcCtD
Fosinopril—Gastrointestinal pain—Prednisone—systemic scleroderma	1.27e-05	0.000205	CcSEcCtD
Fosinopril—Hyperhidrosis—Methotrexate—systemic scleroderma	1.25e-05	0.000202	CcSEcCtD
Fosinopril—Anorexia—Methotrexate—systemic scleroderma	1.23e-05	0.000199	CcSEcCtD
Fosinopril—Urticaria—Prednisone—systemic scleroderma	1.23e-05	0.000199	CcSEcCtD
Fosinopril—Abdominal pain—Prednisone—systemic scleroderma	1.22e-05	0.000198	CcSEcCtD
Fosinopril—Body temperature increased—Prednisone—systemic scleroderma	1.22e-05	0.000198	CcSEcCtD
Fosinopril—Hypotension—Methotrexate—systemic scleroderma	1.21e-05	0.000195	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	1.18e-05	0.000191	CcSEcCtD
Fosinopril—Insomnia—Methotrexate—systemic scleroderma	1.17e-05	0.000189	CcSEcCtD
Fosinopril—Paraesthesia—Methotrexate—systemic scleroderma	1.16e-05	0.000188	CcSEcCtD
Fosinopril—Dyspnoea—Methotrexate—systemic scleroderma	1.15e-05	0.000186	CcSEcCtD
Fosinopril—Somnolence—Methotrexate—systemic scleroderma	1.15e-05	0.000186	CcSEcCtD
Fosinopril—Hypersensitivity—Prednisone—systemic scleroderma	1.14e-05	0.000184	CcSEcCtD
Fosinopril—Dyspepsia—Methotrexate—systemic scleroderma	1.14e-05	0.000184	CcSEcCtD
Fosinopril—Decreased appetite—Methotrexate—systemic scleroderma	1.13e-05	0.000182	CcSEcCtD
Fosinopril—Fatigue—Methotrexate—systemic scleroderma	1.12e-05	0.00018	CcSEcCtD
Fosinopril—Asthenia—Prednisone—systemic scleroderma	1.11e-05	0.00018	CcSEcCtD
Fosinopril—Pain—Methotrexate—systemic scleroderma	1.11e-05	0.000179	CcSEcCtD
Fosinopril—Pruritus—Prednisone—systemic scleroderma	1.1e-05	0.000177	CcSEcCtD
Fosinopril—Feeling abnormal—Methotrexate—systemic scleroderma	1.07e-05	0.000172	CcSEcCtD
Fosinopril—Diarrhoea—Prednisone—systemic scleroderma	1.06e-05	0.000171	CcSEcCtD
Fosinopril—Gastrointestinal pain—Methotrexate—systemic scleroderma	1.06e-05	0.000171	CcSEcCtD
Fosinopril—Urticaria—Methotrexate—systemic scleroderma	1.03e-05	0.000166	CcSEcCtD
Fosinopril—Dizziness—Prednisone—systemic scleroderma	1.02e-05	0.000165	CcSEcCtD
Fosinopril—Body temperature increased—Methotrexate—systemic scleroderma	1.02e-05	0.000165	CcSEcCtD
Fosinopril—Abdominal pain—Methotrexate—systemic scleroderma	1.02e-05	0.000165	CcSEcCtD
Fosinopril—Vomiting—Prednisone—systemic scleroderma	9.85e-06	0.000159	CcSEcCtD
Fosinopril—Rash—Prednisone—systemic scleroderma	9.77e-06	0.000158	CcSEcCtD
Fosinopril—Dermatitis—Prednisone—systemic scleroderma	9.76e-06	0.000158	CcSEcCtD
Fosinopril—Headache—Prednisone—systemic scleroderma	9.71e-06	0.000157	CcSEcCtD
Fosinopril—Hypersensitivity—Methotrexate—systemic scleroderma	9.54e-06	0.000154	CcSEcCtD
Fosinopril—Asthenia—Methotrexate—systemic scleroderma	9.29e-06	0.00015	CcSEcCtD
Fosinopril—Nausea—Prednisone—systemic scleroderma	9.2e-06	0.000149	CcSEcCtD
Fosinopril—Pruritus—Methotrexate—systemic scleroderma	9.16e-06	0.000148	CcSEcCtD
Fosinopril—Diarrhoea—Methotrexate—systemic scleroderma	8.86e-06	0.000143	CcSEcCtD
Fosinopril—Dizziness—Methotrexate—systemic scleroderma	8.56e-06	0.000138	CcSEcCtD
Fosinopril—Vomiting—Methotrexate—systemic scleroderma	8.23e-06	0.000133	CcSEcCtD
Fosinopril—Rash—Methotrexate—systemic scleroderma	8.16e-06	0.000132	CcSEcCtD
Fosinopril—Dermatitis—Methotrexate—systemic scleroderma	8.16e-06	0.000132	CcSEcCtD
Fosinopril—Headache—Methotrexate—systemic scleroderma	8.11e-06	0.000131	CcSEcCtD
Fosinopril—Nausea—Methotrexate—systemic scleroderma	7.69e-06	0.000124	CcSEcCtD
